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Abstract 
 
Background: Numerous dietary factors are related to the 
development of metabolic syndrome(MS). Several studies suggest that 
antioxidant nutrients may play a protective role in this complex disorder. The 
goal of the present study was to characterize the relationship between retinol 
intake and the prevalence of metabolic syndrome in a defined population 
sample. 
Methods: This cross-sectional study was conducted in a sample of 
2983 men drawn from the Korean Genomic Rural Cohort Study. Dietary 
intake, including retinol intake, was assessed using a semiquantitative food 
frequency questionnaire. We evaluated the prevalence and odds ratios of 
metabolic syndrome by quartile of retinol intake.  
Results: Participants with metabolic syndrome reported 
significantly lower retinol intake than normal subjects. The prevalence of 
metabolic syndrome and the adjusted odds ratio were both decreased in the 
highest quartile of retinol intake [OR: 0.64 (95% CI, 0.483-0.847)] 
compared with the lowest quartile. Participants in the highest quartile also 
had higher body mass indexes (BMI), and waist and hip circumferences, but 
lower systolic blood pressures and serum triglyceride levels than those in 
iii 
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the lowest quartile. Retinol intake showed significant negative correlations 
with each metabolic component except HDL cholesterol. 
Conclusion: Our analysis revealed an inverse association between 
retinol consumption and the prevalence of metabolic syndrome in a large 
sample of Korean men. In this study, systolic blood pressure and serum 
triglycerides were the main risk factors associated with retinol intake. 
 
Key Wards: Retinol, Metabolic syndrome, Korean Genomic Rural Cohort
Introduction 
Metabolic syndrome(MS) is influenced by a cluster of risk factors that 
are  associated to type 2 diabetes mellitus and cardiovascular disease, all of 
which may lead to mortality (1-4). Diabetes and cardiovascular disease are 
showed features of oxidative stress, and some studies suggests that 
antioxidant nutrients, which suppress oxidative injury by inactivating free 
radicals, may offer protection from these conditions (5). 
Reports documented that various dietary factors are related not only to 
individual components of metabolic syndrome but also to the prevalence of 
metabolic syndrome. For example, higher intakes of fruits and vegetables are 
associated with lower prevalence of metabolic syndrome (6-8). But few 
studies have investigated the relationships between individual antioxidant 
nutrients and metabolic syndrome. In data from the Third National Health and 
Nutrition Examination Survey (NHANES), subjects with metabolic syndrome 
showed suboptimal concentrations of antioxidants such as vitamin A, C, E, 
carotenoids, and selenium (9). Another study reported an inverse correlation 
between metabolic syndrome and concentrations of dietary vitamin A and E 
(10). However, data regarding the relationship between dietary retinol intake 
and the prevalence of metabolic syndrome are lacking.   
In this study, we investigated the relationship between dietary retinol 
intake and the prevalence of metabolic syndrome in a large sample of Korean 
men drawn from the Korean Genomic Rural Cohort (KGRC). In addition, we 
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evaluated the relationship between retinol intake and metabolic syndrome 
components. 
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Subjects and methods 
1. Study sample 
For this cross-sectional study, we enrolled subjects from the Korean 
Rural Genomic Cohort (KGRC) of 2006. The 4089 male KGRC participants, 
ranging in age from 40 to 70 years, came from the five communities of 
Wonju, Pyeongchang, Naju, Keumsan, Kangreung in South Korea. We 
excluded participants who were taking medications for hypertension, 
hyperlipidemia, and diabetes mellitus, and subjects with missing data 
(n=1106). In total, we included 2983 participants in the present study. 
 
2. Data collection 
After obtaining written informed consent from participants, we 
conducted interviews and anthropometric examinations. Trained 
interviewers obtained basic demographic data, medical histories, and 
information about personal habits, including diet, smoking, alcohol intake, 
physical activity, family history and medication use. After eight hours of 
fasting, blood samples were collected for analysis of biochemical markers. 
Insulin resistance was calculated using the homeostasis model assessment 
(HOMA-IR) (11), using the following formula: fasting insulin (µU/mL) x 
fasting plasma glucose (mg/dL) /22.5. The usual dietary intakes were 
assessed by a 103-item interviewer-administered semiquantitative food 
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frequency questionnaire (FFQ) (12). The dietary record was analyzed 
using the DS 24 (Human Nutrition Lab, Seoul National University and AI/DB 
Lab., Sookmyung Women’s University) with values drawn from the Food 
Composition Table of Korea, Seventh Edition (13). 
 
3. Metabolic syndrome 
Metabolic syndrome was defined according to modified NCEP-ATP 
III guidelines, applying the Asia-Pacific waist circumference values 
(14,15). A diagnosis of metabolic syndrome was made if a subject showed 
three or more of the following abnormalities: waist circumference ≥90 cm 
in men or ≥80 cm in women, serum triglycerides ≥ 150 mg/dL, HDL 
cholesterol <40 mg/dL in men or <50 mg/dL in women, blood pressure ≥ 
130/85 mm Hg, and fasting blood glucose ≥ 100 mg/dL.  
 
4. Statistical analysis 
Statistical calculations were performed using SPSS for Windows 
(v.11). We used Student ’ s t-test to compare the dietary, anthropometric, 
and biochemical characteristics of subjects with and without metabolic 
syndrome. Multivariate stepwise logistic regression analyses were 
performed to estimate odds ratios and 95% confidence intervals for the 
prevalence of metabolic syndrome by quartile of retinol intake. We 
performed ANOVA to evaluate anthropometric and biochemical 
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characteristics by quartile of retinol intake. P-values less than 0.05 were 
considered statistically significant. 
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Results 
1. Anthropometric and biochemical characteristics of 
subjects 
Subjects with metabolic syndrome had significantly higher BMIs, waist 
circumferences, hip circumferences, and waist-to-hip ratios (WHR) than 
normal subjects. Total cholesterol, triglyceride, LDL cholesterol, AST, ALT, 
GGT, HOMA-IR, fasting and postprandial glucose and insulin levels were 
significantly higher in subjects with metabolic syndrome, while HDL 
cholesterol and adiponectin levels were significantly lower than in normal 
subjects (Table 1). 
 
Table 1. Characteristics of subjects with and without metabolic syndrome  
 Non-MS (n=2178) MS (n=805) 
Age  56.76±8.16 55.57±8.02 
Height (cm)  165.73±5.64 166.94±5.58 
Weight (kg)  63.56±8.48 72.09±9.45 
BMI (kg/m2)  23.25±2.61 25.92±3.05* 
Waist circumference (cm) 83.06±7.12 90.68±7.08* 
Hip circumference (cm) 93.45±5.80 97.96±6.58* 
WHR  0.88±0.06 0.92±0.06* 
SBP (mmHg)  128.24±16.38 139.28±16.31 
DBP (mmHg)  82.01±10.74 88.53±10.93 
FPG (mg/dL) 93.27±13.85 105.21±29.36* 
PPG (mg/dL) 105.42±60.24 122.37±87.31* 
Fasting insulin (mIU/L) 6.94±3.54 9.97±6.19* 
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Table 1. Characteristics of subjects with and without metabolic syndrome 
(continued) 
 Non-MS (n=2178) MS (n=805) 
Postprandial insulin (mIU/L) 20.06±19.89 28.61±28.34* 
HOMA-IR 29.23±18.49 47.82±42.71* 
HbA1C (%)  5.53±0.69 5.81±0.88 
Adiponectin (μg/dL) 8.93±4.46 6.60±3.65* 
AST (IU/L) 31.55±18.75 34.48±23.25* 
ALT (IU/L) 27.82±17.77 35.69±22.38* 
GGT (IU/L) 53.47±97.03 87.03±171.92* 
Total cholesterol (mg/dL)  196.25±36.16 204.26±41.82* 
Triglyceride (mg/dL)  135.99±86.88 251.90±178.56* 
HDL-cholesterol (mg/dL) 47.92±11.73 38.15±8.47* 
LDL-cholesterol (mg/dL) 112.89±31.34 114.56±33.36* 
WBC(109/L)   7.29±2.02 7.66±2.00 
CRP(mg/dL) 2.07±5.43 2.55±7.16 
Alcohol(g/day) 31.32±113.70 45.46±213.89 
Smoking(pack years) 19.99±19.63 21.55±21.45 
Exercise(%) 22.6 26.0 
Data are represented by mean ± SD. MS, metabolic syndrome; BMI, body mass 
index; WHR, waist-hip ratio; SBP, systolic blood pressure; DBP, diastolic blood 
pressure; FPG, fasting plasma glucose; PPG, postprandial glucose; HOMA-IR, 
homeostasis assessment model for insulin resistance; AST, aspartate 
aminotransferase; ALT, alanine aminotransferase; GGT, γ-glutamyltransferase; 
HDL, high density lipoprotein; LDL, low density lipoprotein; WBC, white blood cells; 
CRP, C-reactive protein. *: p<0.05 compared with non-MS group. 
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2. Comparison of dietary factors between subjects with and 
without metabolic syndrome  
Of all dietary factors analyzed, only retinol intake was significantly 
lower in subjects with metabolic syndrome than in those without metabolic 
syndrome (Table 2). 
 
Table 2. Dietary factors in subjects with and without metabolic syndrome 
 Non-MS (n=2178) MS (n=805) 
Total Energy (kcal/d)  1849.83±528.95 1889.04±552.85 
Protein (g/d)  59.81±25.13 61.79±26.78 
Fat (g/d)  27.48±25.79 27.55±21.56 
Carbohydrates (g/d)  332.73±85.52 339.16±86.88 
Calcium (mg/d)  418.65±260.46 419.54±264.39 
Phosphorus (mg/d)  910.88±347.17 929.47±335.63 
Iron (mg/d)  9.98±6.39 10.13±5.49 
Sodium (g/d)  3137.22±1960.63 3157.66±1936.17 
Potassium (g/d)  2200.27±1247.04 2235.22±1133.64 
Fiber (g/d)  5.97±3.38 6.07±3.21 
Vit A (mg/d)  500.87±477.73 503.66±410.94 
Vit B1 (mg/d)  1.07±0.69 1.08±0.53 
Vit B2 (mg/d)  0.88±0.57 0.89±0.48 
Vit B12 (µg /d)  14.09±8.52 14.43±6.69 
Vit C (mg/d)  99.86±75.54 102.43±6.69 
Zinc (mg/d)  7.64±4.89 7.93±4.15 
Folate (µg /d)  211.73±145.74 216.87±135.72 
Retinol (µg /d)  52.24±53.80 51.18±58.14* 
Carotene (mg/d)  2602.89±2529.11 2624.55±2258.14 
Data are represented by mean ± SD. MS, metabolic syndrome; vit, vitamin.  
*: p<0.05 compared with non-MS group. 
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3. Prevalence of metabolic syndrome by  the quartile of 
various dietary factors 
The prevalence of metabolic syndrome decreased significantly with 
increasing quartile of retinol intake (Table 3). The distribution of retinol 
intake by quartile was less than 15.7 µg in the lowest quartile; 15.7 to 35.05 
µg in the second quartile; 35.06 to 68.55 µg in the third quartile; and more 
than 68.55 µg in the highest quartile. Compared to the lowest quartile of 
retinol intake, multivariate-adjusted odds ratios for metabolic syndrome in 
the higher quartiles were as follows: 0.85 (95% CI, 0.67-1.08), 0.85 (95% 
CI, 0.66-1.09) and 0.64 (95% CI, 0.48-0.84), respectively.  
 
Table 3. Prevalences and odds ratios of metabolic syndrome by the quartile of retinol 
intake 
 Quartile of retinol intake 
 1Q 2Q 3Q 4Q 
P  for 
trend 
Prevalence 
of MS (%) 
192/674 
(28.5%) 
216/801 
(27.0%) 
212/752 
(28.2%) 
185/756  
(24.5%) 
0.290 
Odds ratio 
(95% CI) 
    
 
Model 1 1 
0.91 
(0.72-1.15) 
0.95 
(0.75-1.20) 
0.78 
(0.61-0.99) 
0.154 
Model 2 1 
0.85 
(0.67-1.08) 
0.85 
(0.66-1.09) 
0.64 
(0.48-0.84) 
0.068 
C.I., confidence interval; Q, quartile. Model 1 was adjusted for age. Model 2 was 
adjusted for Model 1 plus total energy, smoking, alcohol, and exercise. 
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4. Metabolic risk factors in male participants by the quartile 
of retinol intake. 
Compared with participants in the lowest quartile, those in the highest 
quartile of retinol intake were younger and had higher body mass indexes 
(BMI), and waist and hip circumferences, but lower systolic blood pressures 
and serum triglyceride levels. Diastolic blood pressure, HDL cholesterol and 
fasting plasma glucose did not differ significantly by quartile. Interestingly, 
mean adiponectin concentrations decreased significantly with increasing 
quartile retinol intake but HOMA-IR did not change. Also, the prevalence of 
subjects who exercised increased significantly with quartile of retinol intake 
(Table 4). 
Retinol intake was lower in participants with each components of 
metabolic syndrome as defined by the modified NCEP-ATP III guidelines 
except for waist circumference than in normal participants (Figure 1A), and 
proportionately lower in participants as the number of metabolic syndrome 
components increased (Figure 1B). 
Table 4. Metabolic risk factors in male participants by the quartile of retinol intake 
 
Characteristics                   Quartile of retinol intake P value 
 1Q (n=674) 2Q (n=801)  3Q (n=752) 4Q (n=756)  
Total energy intake 
(kcal/d) 
1522.49±318.08 1723.94±368.81 1918.46±456.84 2248.25±644.87 <0.001 
Age (year) 58.36±7.74 56.31±7.93 55.88±8.19 55.42±8.38 <0.001 
Height(cm) 165.27±5.69 166.12±5.30 166.19±5.87 166.56±5.66 <0.001 
Weight (Kg) 64.63±7.95 66.13±8.91 65.74±9.79 66.88±9.99 <0.001 
BMI (kg/m2) 23.62±2.89 23.94±2.84 23.76±3.04 24.06±3.01 0.030 
Waist (cm) 84.59±7.96 85.27±7.57 84.83±7.90 85.78±8.06 0.025 
Hip (cm) 94.13±6.22 94.68±5.75 94.51±6.49 95.34±6.89 0.004 
WHR 0.89±0.05
 
 
 
 
 
 
 
 
 
   0.90±0.05 0.89±0.05 0.90±0.05 0.749 
HOMA-IR 34.26±33.86 34.69±25.69 33.34±23.23 34.68±30.66 0.769 
HbA1C(%) 5.62±0.72 5.62±0.81 5.59±0.74 5.57±0.71 0.482 
SBP (mmHg) 132.53±17.77 131.13±16.80 132.05±19.65 129.87±16.44 0.030 
DBP (mmHg) 84.37±11.52 83.43±10.73 83.47±11.25 83.72±11.25 0.434 
FPG (mg/dL) 96.25±22.69 97.25±18.09 96.20±18.89 96.20±20.53 0.670 
PPG (mg/dL) 113.59±66.18 112.78±69.65 105.17±70.35 108.63±69.17 0.069 
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Characteristics                   Quartile of retinol intake P value 
 1Q (n=674) 2Q (n=801)  3Q (n=752) 4Q (n=756)  
Fasting insulin(mIU/L) 7.69±4.28 7.83±4.53 7.64±4.29 7.87±5.27 0.731 
Postprandial insulin 23.84±26.74 22.55±21.89 20.52±18.75 22.35±23.12 0.067 
Adiponectin(μg/dL) 8.81±4.65 8.19±4.11 8.26±4.49 8.13±4.28 0.025 
T. Cholesterol(mg/dL) 197.21±36.70 201.46±41.62 196.64±36.91 198.03±35.73 0.056 
HDL-C (mg/dL) 45.23±12.15 45.34±12.29 44.90±11.13 45.66±11.52 0.654 
LDL-C (mg/dL) 112.96±31.22 114.39±33.41 111.58±31.44 114.32±31.32 0.266 
TG (mg/dL) 165.56±107.85 177.25±160.43 168.98±128.98 156.54±108.49 0.017 
AST(IU/L) 32.83±20.95 32.06±17.10 32.23±21.23 32.33±21.13 0.902 
ALT(IU/L) 29.88±20.33 29.96±18.84 29.85±18.80 30.07±19.92 0.996 
GGT(IU/L) 68.19±176.58 59.27±92.98 65.04±127.77 58.45±79.09 0.370 
WBC(109/L) 7.45±2.11   
   
7.40±2.02 7.32±1.93 7.39±2.03 0.710 
CRP(mg/dL) 2.04±4.64 2.28±7.20 2.50±6.73 1.97±4.51 0.306 
Smoking (pack years) 21.32±20.47 20.74±19.73 19.92±19.81 19.44±20.59 0.310 
Alcohol (g/day) 23.85±117.71 39.76±208.69 33.98±104.65 40.79±112.39 0.366 
Exercise (%)† 15.8 21.9 23.8 31.7 <0.001 
Table 4. Metabolic risk factors in male participants by the quartile of retinol intake (continued) 
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Data are represented by the mean ± SD. BMI, body mass index; HOMA-IR, 
homeostasis assessment model for insulin resistance; SBP, systolic blood pressure; 
DBP, diastolic blood pressure; HDL-C, high density lipoprotein cholesterol; LDL-C, 
low density lipoprotein cholesterol; TG, triglyceride; FPG, fasting plasma glucose; 
AST, aspartate aminotransferase; ALT, alanine aminotransferase; GGT, γ-
glutamyltransferase; WBC, white blood cells; CRP, C-reactive protein; Q, quartile. 
†Percentage of the study participants who consistently exercised enough to perspire.
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Figure 1. Mean retinol intake according to the presence or absence of multiple 
components of metabolic syndrome. (A) Mean retinol intake was lower in subjects 
who had components of metabolic syndrome than in normal subjects. (B) Increase in 
number of metabolic syndrome components corresponds to decreased mean retinol 
intake 
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5. Relationships between retinol intake and components of 
metabolic syndrome 
Retinol intake showed inverse correlations with waist-hip ratio, 
HbA1c, LDL cholesterol, postprandial insulin, postprandial glucose and 
systolic blood pressure. The correlation with HDL cholesterol, however, was 
positive (Table 5). 
 
Table 5. Correlations between retinol intake and components of metabolic syndrome 
 r P value 
Waist-hip  ratio  -0.071 <0.007 
HbA1C  -0.045 0.009 
LDL -0.031 0.047 
TG -0.090 <0.001 
HDL 0.068 <0.001 
Postprandial insulin -0.054 <0.001 
Postprandial glucose -0.075 <0.001 
SBP -0.039 0.014 
r; coefficient of pearsons’correlation 
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Discussion 
 In this study, we determined the prevalence of metabolic syndrome in 
a Korean male population with respect to intakes of various dietary factors, 
and detected a negative correlation between MS and retinol intake only.  
Retinol, one of the most usable forms of vitamin A, is a fat-soluble 
vitamin that functions in vision and bone growth (16). Animal sources such 
as liver and eggs contain the retinyl ester precursor forms, which are 
converted to retinol in the small intestine (17). The pro-vitamin 
A carotenoids from darkly colored fruits and vegetables also serve as dietary 
retinol precursors. 
Previous study supports an association between metabolic syndrome 
with increased oxidative stress (18), which is implicated in diabetes mellitus, 
obesity, and coronary vascular disease, and may also be involved in insulin 
resistance (19, 20). Oxidative stress may contribute to diabetes mellitus 
through impairment of insulin signaling or dysfunction in pancreatic β-cells, 
which contain only low concentrations of radical scavengers (21-24). 
Recent data show that specific nutrients or representative food groups can 
reduce the risk of oxidative stress-related chronic disease (25). 
Aantioxidant components of these foods, including β-carotene, vitamin C, 
and vitamin E, can directly suppress oxidative stress by inactivating free 
radicals. From this, we hypothesized that retinol, as an antioxidant, may 
reduce the risk for metabolic syndrome. This is consistent with results of 
16 
 
prospective studies, which showed a lower prevalence of metabolic 
syndrome at higher carotenoid intake (26), and an association of metabolic 
syndrome or type 2 diabetes mellitus with lower concentrations of serum 
carotenoids (27,28). 
The results of our study revealed a relationship between higher retinol 
consumption and decreased prevalence of metabolic syndrome. Subjects in 
the highest quartile of retinol intake showed a prevalence of metabolic 
syndrome 36% lower than in the lowest quartile. This inverse relationship 
extended to each component of the metabolic syndrome, including serum 
triglyceride concentration and systolic blood pressure. However, we also 
found that subjects in the highest retinol intake group had higher weight, 
body mass index (BMI), and waist and hip circumference compared with 
those who had lowest retinol intake. This discrepancy may reflect an 
increased intake of other nutrients in the highest quartile of retinol intake. 
Retinol intake was lower in subjects with each component of metabolic 
syndrome except for waist circumference than in normal subjects. 
Furthermore, retinol consumption in subjects with multiple components of 
metabolic syndrome was proportionately lower than in subjects with fewer 
components. From these findings, we surmised that retinol may have a 
protective effect in the development of metabolic syndrome. 
Adiponectin is a novel adipose tissue-specific polypeptide that may 
counteract atherosclerosis and insulin resistance (29). Studies show lower 
adiponectin levels in type 2 diabetes mellitus, obesity and insulin resistance 
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(30). In this study, we found significantly lower mean adiponectin levels as 
retinol intake increased. HOMA-IR and CRP , which are predictive factors 
for diabetes mellitus and metabolic syndrome, also were not correlated with 
retinol intake. We suggest that the lower adiponectin level in subjects with 
the highest retinol intake is related to the proportionately higher waist 
circumference and BMI in this group, independent of metabolic syndrome 
status. 
Although our findings support a protective role for retinol in metabolic 
syndrome, we did not measure oxidative stress markers, and thus could not 
test the relationship between oxidative stress and retinol intake. Studies 
show, however, that vitamin A supplementation may reduce hypertension by 
enhancing synthesis of prostaglandin E1 and platelet aggregation inhibitors, 
and may also influence lipid metabolism (31). Barber et al. found significant 
changes in mitochondrial membrane lipid composition and function, and 
suggested that chronic vitamin A deficiency may decrease membrane lipid 
turnover (32). Based on measurements of lipid peroxidation in the 
mitochondria, they emphasized the antioxidant role of vitamin A in the 
maintenance of lipid composition (32). 
In conclusion, of the nutritional factors we tested, only retinol intake 
showed a significant negative correlation with the prevalence of metabolic 
syndrome. Our findings suggest that higher retinol intake may reduce the 
risk for metabolic syndrome, and also for components of metabolic syndrome. 
We identified systolic blood pressure and serum triglyceride level as the 
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main risk factors associated with retinol intake in this study. However, to 
determine whether the antioxidant properties of retinol offer protection from 
metabolic abnormalities will require further cohort or intervention studies. 
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국 문 요 약 
연구배경: 대사증후군은 제 2 형 당뇨병 및 심혈관 질환과 연관되어 있고 
세계적으로 그 유병률이 증가 추세에 있으나 대사증후군에서 영양 및 식사의 
역할은 아직 논란이 많다. 저자들은 한국 지역사회 유전체 코호트에 참여한 
남성을 대상으로 영양 및 식사패턴과 대사증후군과의 연관성을 규명하고자 
하였다.  
방법: 2006 년 한국 지역사회 유전체 코호트 중 원주, 평창, 강릉, 나주, 
금산에 거주하는 40 세 이상 70 세 이하의 남자 4089 명을 대상으로 하였다. 이 
중 식사패턴에 영향을 줄 수 있는 항고혈압약제, 혈당강하제, 고지혈증약제 
처방을 받고 있는 환자를 제외한 총 2983 명이 참여하였다. 이들은 
식품섭취빈도조사지를 비롯한 설문을 통하여 생활습관, 의학적 기왕력 및 
식사력을 제공하였으며 신장, 체중, 혈압 및 허리-엉덩이 둘레의 비 등의 
신체계측과 공복 및 식후 정맥채혈을 시행하였다. 대사증후군의 진단기준으로는 
NCEP-ATP III 의 기준을 보완하여 이용하였다. 
결과: 대사증후군이 있는 군에서 레티놀의 섭취량이 낮았다. 또한 각 
영양소를 4 분위수로 나눈 후 레티놀의 섭취가 증가할수록 대사증후군의 
비교위험률은 감소하였다[2nd quartile OR:0.85(95% CI: 0.67-1.08), 3rd 
quartile OR: 0.85(95% CI: 0.66-1.09), 4th quartile OR: 0.64 (95% CI: 0.48-
0.84)]. 레티놀의 섭취가 많은 군에서 대사증후군의 구성요소 중 수축기 혈압과 
혈중 중성지방의 수치가 의미있게 감소하였다. 또한 레티놀의 섭취량은 비만도와 
당화혈색소, LDL 콜레스테롤, 식후혈당, 식후인슐린 및 수축기혈압과 음의 
상관관계를 나타내었고 HDL 콜레스테롤과는 양의 상관관계를 보였다. 
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결론: 한국인 남성에서 레티놀 섭취는 대사증후군의 각 요소들과 
상관관계를 보이고 특히 레티놀의 섭취가 많은 그룹에서 수축기혈압과 
중성지방이 의미있게 감소함을 알 수 있었다. 이는 충분한 레티놀의 섭취는 
대사증후군의 유병률을 감소시킬 수 있음을 시사한다. 따라서 이에 대한 대규모 
임상 연구가 필요할 것으로 생각된다. 
 
중심단어: 레티놀, 대사증후군, 지역사회 코호트 
 
